Evidence map›Paper›PMID 38235113›Full record

ArticleFrontiers in pharmacology2023

Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor

Iméne Ben Toumia, Tiziana Bachetti, Leila Chekir-Ghedira, Aldo Profumo, Marco Ponassi, Alessandro Di Domizio, Alberto Izzotti, Salvatore Sciacca, Caterina Puglisi, Stefano Forte and 15 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 2 countries.

Iméne Ben Toumia *IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Tiziana Bachetti *IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Leila Chekir-GhediraUnit of Bioactive Natural Substances and Biotechnology, Faculty of Dental Medicine of Monastir, University of Monastir, Monastir, Tunisia.
Aldo ProfumoIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Marco PonassiIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Alessandro Di DomizioSPILLOproject, Milano, Italy.
Alberto IzzottiIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Salvatore SciaccaIstituto Oncologico del Mediterraneo, Viagrande, Italy.
Caterina PuglisiIstituto Oncologico del Mediterraneo, Viagrande, Italy.
Stefano ForteIstituto Oncologico del Mediterraneo, Viagrande, Italy.
Raffaella GiuffridaIstituto Oncologico del Mediterraneo, Viagrande, Italy.
Cristina ColarossiIstituto Oncologico del Mediterraneo, Viagrande, Italy.
Danilo MilardiIstituto di Cristallografia, Consiglio Nazionale delle Ricerche, Catania, Italy.
Giuseppe GrassoDepartment of Chemical Sciences, University of Catania, Catania, Italy.
Valeria LanzaIstituto di Cristallografia, Consiglio Nazionale delle Ricerche, Catania, Italy.
Stefano FiordoroDepartment of Experimental Medicine, University of Genova, Genova, Italy.
Giacomo DragoDepartment of Experimental Medicine, University of Genova, Genova, Italy.
Kateryna TkachenkoIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Barbara CardinaliIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Paolo RomanoIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Erika IervasiIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Gabriela Coronel VargasIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Paola BarboroIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Franz Heinrich KohnkeDipartimento di Scienze Chimiche, Farmaceutiche ed Ambientali (CHIBIOFARAM), University of Messina, Messina, Italy.
Camillo RosanoIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Ospedale Policlinico San Martino · ITUniversity of Genoa · ITInstitute of Crystallography · ITUniversity of Catania · ITUniversity of Messina · ITUniversity of Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

calix[4]pyrrolescancerdrug discoverynon-small-cell lung cancerproteomicstarget discovery

Identifiers

PMID38235113
PMCPMC10791888
OpenAlexW4390542654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.